Andrés Pizzorno
🇺🇾 Virologist (INSERM) tackling #respiratory #viruses at 🇫🇷 VirPath team (CIRI). Adj. Investigator at 🇸🇬 A*STAR ID Labs. Views are my own.
- Merci CIRI @ciri-lyon.bsky.social pour la mise en lumière de projet STANDBYME et merci aussi à l'ANR @agencerecherche.bsky.social pour la confiance et le soutien à ma recherche sur les #virus respiratoires.
- Chaque année, plusieurs équipes du CIRI répondent à l'appel à projet générique de l'@agencerecherche.bsky.social. Cette année, 12 de nos projets se verront apporter son soutien, mais en quoi consistent-ils? Vous pouvez à présent tout savoir sur ces projets sur notre site: tinyurl.com/595kuyvt
- It's tomorrow 👇
- 🚨Webinar alert!🚨 #ISIRV webinar next Tue Apr 15th, 1pm GMT on the highlights of the recent #RSV2025 meeting! Six (6!) top speakers aligned. Open to everyone, free but mandatory registration through this link: register.gotowebinar.com/register/489... #RSV #virology #virus #science
- 🚨Publication alert🚨 Our study "Host-targeted repurposed diltiazem enhances the antiviral activity of direct acting antivirals against Influenza A virus and SARSCOV2" has been published in Antiviral Research. Find the open acces manuscript here: doi.org/10.1016/j.anti… 1/-👇
- In this study, we characterized the first-in-class antiviral MoA #diltiazem as a modulator of the endogenous IFN-λ response in the respiratory airway. We performed software-assisted combination scenarios in both human respiratory cell lines and Human Airway Epithelia...
- L’Inserm est solidaire du mouvement Stand Up For Science presse.inserm.fr/cest-dans-la... #StandUpForScience2025
- Reposted by Andrés Pizzorno[Not loaded yet]
- Gracias Federico Martínez de @debateuy.bsky.social por la muy buena charla sobre virus, pandemias y desinformación. Y una mención de honor a @fcienciasugr.bsky.social, donde todo comenzó. www.debate.com.uy/actualidad/A...
- Reposted by Andrés Pizzorno
- Merci à l'INSERM @inserm.fr pour cette belle mise en lumière. @ciri-lyon.bsky.social #virology www.linkedin.com/posts/inserm...
- Reposted by Andrés Pizzorno[Not loaded yet]
- Bravo @loicguillot.bsky.social et @olivierterrier.bsky.social for leading this beautiful work. #virology
- 🚨ISIRV Webinar: Advances in Respiratory Viral Infection Antivirals 📆Wed Feb 19th, 2:00pm GMT 🗣️Anthony Gordon @imperialcollegeldn.bsky.social, Jeffery Nielsen, Annie Luetkemeyer @ucsfmedicine.bsky.social ✍️Free registration to attend live/on demand: register.gotowebinar.com/register/223... #virology
- Reposted by Andrés Pizzorno[Not loaded yet]
- Waaay too late, but better late than never 👇
- 🚨1 week to go, Fri 13th 3pm CET! Register for free bit.ly/3ZnjSSP to attend live or on demand the last ISIRV webinar of the year on ‘RSV prophylaxis – real world experience and impact’. ISIRV and non ISIRV members are welcome. #virology #rsv #webinar #isirv
- A must read reality check. And btw, congratulations @frantecol.bsky.social et al. for the resilience!
- Science takes time - a lot of time. Time that is more and more difficult to make available because of increased workloads. Time that exceeds the temporary contracts of postdocs and PhDs. I'll illustrate this using our paper published in Nature yesterday. 🧵 (1/x) www.nature.com/articles/s41...
- The next ISIRV 2024 webinar is scheduled for 13 December 2024. The topic will be ‘RSV prophylaxis – real world experience and impact’ Register here: bit.ly/3ZnjSSP We welcome iSIRV and non ISIRV members to attend - there is no fee to attend. #rsv #webinar #isirv
- Reposted by Andrés PizzornoCouldn’t find a virology starter pack so here’s one to get the ball rolling. Repost/reply if you are a virologist so I can find and add you to the list! go.bsky.app/SinqoJUat://did:plc:7fwzucrzygtrp3fj2n4m6kag/app.bsky.graph.starterpack/3lalz5ul6mm2j
- 🚨Últimos días para inscribirse. Todo lo que usted quería saber sobre antivirales.. y temía preguntar..😉 No te quedes afuera del curso!!!
- Reposted by Andrés PizzornoThe preliminary sequence from the H5N1 human case in British Columbia has been posted and it is not good news. The virus potentially has a quasispecies at HA residue 226 (H3 numbering). This is bad news because we know that mutations at residue 226 can increase binding to human receptors. 1/
- Reposted by Andrés Pizzorno[Not loaded yet]
